CDK4 and synovial sarcoma: The inhibition of cyclin-dependent kinases 4 and 6 (CDK4/6) has emerged as a potential treatment option for a select number of STS subtypes, such as SS, due to the potent cell cycle arrest and induction of apoptosis observed in vitro [100].